StockTipsArenaBeta

BUY Akums Drugs and Pharmaceuticals — ICICI Securities

BUYAkums Drugs and Pharmaceuticals
Akums Drugs and Pharmaceuticals share price target & all analyst calls

byICICI SecuritiesHorizon: NA (inferred 1 year)22 Dec 2025via Institutional / Brokerage Research

Entry₹443.15Inferred
Target₹600
Total upside +35.39% (call closed)
Stop lossNot given
Exit₹60011 Jun 2026, 12:06 pm
Target hit+35.39%0.00%upside left
Follow ICICI Securities for new calls(67% target hit, 1026 closed calls)Get alertsWatch AKUMS for new buy/sell callsGet alertsSee 3 active Long-term calls on AKUMSSee 214 active Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 23 Oct, 5:55 am IST
2 supporting2 neutral0 opposing
Supports the BUY call (2)

1 advisor has an active short-term BUY call on this stock, issued in the last 14 days

Advisor consensus · adjacent horizon·11 Jun · today

Akums Drugs and Pharmaceuticals reported Q4 FY26 operating revenue of ₹1,158 crore (up 9.7% YoY) and Adj EBITDA of ₹152 crore (up 61.6% YoY). Full-year FY26 revenue was ₹4,359 crore and Adj EBITDA was

NSE · Press Release·14 May · 4w ago

(opens in new tab)
Neutral / worth noting (2)

Company received assessment order(s) from the Income Tax Department.

BSE · Company Update·20 May · 3w ago

(opens in new tab)

Akums Drugs and Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.

NSE · Outcome of Board Meeting·14 May · 4w ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Akums Drugs and Pharmaceuticals

All analyst calls on Akums Drugs and Pharmaceuticals

More from ICICI Securities

Every call and its outcome